Good morning, and welcome to Stockhead’s Top 10 at somewhere near 11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms that have made announcements.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.

Briefly, here’s what’s been happening already this morning.

The ASX 200 made a bold, quick chip’n’chase and regather straight after kick-off this morning, with a jinking side-step or two, but was brought down hard in a midfield gang tackle. The local market, taken as a whole, is currently attempting to shore up field position with the slimmest of leads (+0.05%).

One of the main factors of play is, of course, the escalating tensions and indeed destruction wrought by missile ping pong happening over in the Middle East right now.

Meanwhile, as Eddy reported in Market Highlights a short while ago:

On Wall Street overnight, major indexes crept slightly higher as investors remained cautious ahead of the September jobs data coming out on Friday.

The S&P 500 was up by 0.01%, the blue chips Dow Jones index rose by 0.09%, and the tech heavy Nasdaq climbed by 0.08%.

Data released last night indicated that US companies added more jobs than anticipated last month, which contrasts with other signals pointing to a slowing labour market.

The upcoming non-farm payrolls report on Friday will provide another check for the overall health of the US economy, which will also influence the Fed’s upcoming interest rate decision.

Here’s what’s moving and shaking on the ASX at the time of writing…

 

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Wordpress Table Plugin

In the news this morning we have…

Island Pharmaceuticals (ASX:ILA) up at least 50% at the time of writing. The mid-clinical-stage biotech company has come off a trading halt with some good news this morning, having secured $3.5m in new funding to “support key inflection points and pipeline build”.

What the latter means, is the fresh funding will go towards the completion of the company’s ISLA-101 Phase 2a/b clinical trial in dengue fever, following dosing of Phase 2a subjects, announced earlier today. The capital will also help advance the due diligence program for antiviral therapeutic, Galidesivir.

Meanwhile, in ressie land, Golden Mile Resources (ASX:G88) has announced further encouraging results from its Pearl Copper project in Arizona, USA. It’s talking sighting of “visible copper” with pXRF results highlighting polymetallic potential including: copper values up to 13.4%, lead values up to 1.29% and zinc values up to 7.22%

 

LAGGARDS

Stocks highlighted in red have made market-moving announcements (click headings to sort).

Wordpress Table Plugin

 

At Stockhead we tell it like it is. While Island Pharmaceuticals and Golden Mile Resources are Stockhead advertisers at the time of writing, they did not sponsor this article.